News
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...
Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...
The FDA has rehired at least some workers tasked with releasing public records generated by the agency’s regulatory ...
A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results